[1]桑梓楠张凤伟.应用Cardioband系统治疗功能性二尖瓣反流的研究进展[J].心血管病学进展,2020,(10):1049.[doi:10.16806/j.cnki.issn.1004-3934.20.10.012]
　Zinan ZHANG Fengwei.Treating Patients Suffering Functional Mitral Regurgitation by Cardioband SystemSANG[J].Advances in Cardiovascular Diseases,2020,(10):1049.[doi:10.16806/j.cnki.issn.1004-3934.20.10.012]
点击复制

应用Cardioband系统治疗功能性二尖瓣反流的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年10期
页码:
1049
栏目:
综述
出版日期:
2020-10-25

文章信息/Info

Title:
Treating Patients Suffering Functional Mitral Regurgitation by Cardioband SystemSANG
作者:
桑梓楠1; 2张凤伟2
（1.山东第一医科大学（山东省医学科学院） 研究生院，山东 泰安 271000；2.临沂市人民医院 心脏外科，山东 临沂 276000）
Author(s):
Zinan 1; 2 ZHANG Fengwei 2
(1.School of Graduate Shandong First Medical University & Shandong Academy of Medical Sciences,Taian,271000,Shandong,China;2.Department of Cardiac Surgery, Linyi People’s Hospital,Linyi,276000,Shandong,China)
关键词:
Cardioband系统; 功能性二尖瓣反流; 经皮二尖瓣环成形术
Keywords:
Cardioband System;  Functional mitral regurgitation; Percutaneous mitral?annuloplasty
DOI:
10.16806/j.cnki.issn.1004-3934.20.10.012
摘要:
功能性二尖瓣反流是指瓣膜结构正常或接近正常，继发于左室及收缩功能障碍的二尖瓣闭合不全。其大多合并缺血性或非缺血性心肌病、心力衰竭等，往往提示预后不良。相较于退行性二尖瓣反流，功能性二尖瓣反流的外科治疗尚未被证明具有显著获益。Cardioband系统是首个达到外科手术效果的经皮二尖瓣环成形设备，它通过介入的方式将特制的成形环准确固定于二尖瓣环处，有效缩减二尖瓣环尺寸以降反流量。Cardioband系统在危功能性二尖瓣反流患者的治疗中具有良好的安全性和有效性，但其适用人群远期疗效仍更多的临床试验进一步探索。
Abstract:
Functional mitral regurgitation (FMR) is the mitral insufficiency that occurs without organic mitral valve disease and secondary to left ventricular remolding and dysfunction. It is usually complicated with the ischemic/nonischemic cardiomyopathy and heart failure, which associated with a worse prognosis. Compared to degenerative mitral regurgitation, the benefits of MV surgery are uncertain. The Cardioband system is the first percutaneous annuloplasty device to achieve surgical result. This device can accurately fix the special annuloplasty band to mitral annulus and efficiently reduce annular dimensions and regurgitant volume. It has demonstrated safety and efficiency in high-risk patients with FMR, but the applicable standard and long-term prognosis still need to be explored by more coherent clinic trial.

参考文献/References:

[1] Asgar AWMack MJ,Stone GW. Secondary mitral regurgitation in heart failure:pathophysiology,prognosis,and therapeutic considerations[J].?J Am Coll Cardiol,2015,65(12):1231-1248.
[2] Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC).Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J].?Eur Heart J,2016,37(27):2129-2200.
[3] Yucel E,Santana O,Escolar E,et al. Cardioband for the treatment of secondary mitral regurgitation:a viable percutaneous option?[J]. J Thorac Dis,2017,9(Suppl 7):665-667.
[4] Tabata N,Sugiura A,Tsujita K,et al. Percutaneous interventions for mitral and tricuspid heart valve diseases[J].?Cardiovasc Interv Ther,2020,35(1):62-71.
[5] Baumgartner H,Falk V,Bax JJ,et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease[J].?Eur Heart J,2017,38(36):2739-2791.
[6] Lavall D,Hagendorff A,Schirmer SH,et al. Mitral valve interventions in heart failure[J].?ESC Heart Fail,2018,5(4):552-561.
[7] Shah T,Zhong M,Minutello RM. Functional mitral regurgitation in heart failure[J].?Cardiol Rev,2019,27(6):327-336.
[8] Goldstein D,Gelijns AC,Moskowitz AJ. Surgery for severe ischemic mitral regurgitation[J].?N Engl J Med,2016,374 (20):1992-1993.
[9] Obadia JF,Messika-Zeitoun D,Leurent G,et al. Percutaneous repair or medical treatment for secondary mitral regurgitation[J].?N Engl J Med,2018,379(24):2297-2306.
[10] Savic V,Pozzoli A,Gülmez G,et al. Transcatheter mitral valve chord repair[J]. Ann Cardiothorac Surg,2018,7(6):731-740.
[11] Maisano F,Taramasso M. The Cardioband transcatheter direct mitral valve annuloplasty system[J].?EuroIntervention,2015,11(Suppl W):W58-W59.
[12] Miller M,Thourani VH,Whisenant B. The Cardioband transcatheter annular reduction system[J].?Ann Cardiothorac Surg,2018,7(6):741-747.
[13] Khalique OK,Hahn RT. Percutaneous mitral valve repair:multi-modality cardiac imaging for patient selection and intra-procedural guidance[J]. Front Cardiovasc Med,2019,6:142.
[14] Ferrero Guadagnoli A,De Carlo C,Maisano F,et al. Cardioband system as a treatment for functional mitral regurgitation[J].?Expert Rev Med Devices,2018,15(6):415-421.
[15] Nickenig G,Hammerstingl C,Schueler R,et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation:6-month results with the Cardioband percutaneous mitral repair system[J]. JACC Cardiovasc Interv,2016,9(19):2039-2047.
[16] Maisano F,La Canna G,Latib A,et al. First-in-man transseptal implantation of a "surgical-like" mitral valve annuloplasty device for functional mitral regurgitation[J].?JACC Cardiovasc Interv,2014,7(11):1326-1328.
[17] Maisano F,Taramasso M,Nickenig G,et al. Cardioband,a transcatheter surgical-like direct mitral valve annuloplasty system:early results of the feasibility trial[J].?Eur Heart J,2016,37(10):817-825.
[18] Messika-Zeitoun D,Nickenig G,Latib A,et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system:1 year outcomes[J].?Eur Heart J,2019,40(5):466-472.
[19] Weber M,?ztürk C,Taramasso M,et al. Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation[J].?EuroIntervention,2019,15(10):912-918.
[20] 潘文志周达新葛均波. 经导管二尖瓣反流治疗最新进展2018J]. 中国医学前沿杂志(电子版)2018,10(1):1-5.
[21] Nickenig G,Schueler R,Dager A,et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system[J]. J Am Coll Cardiol,2016,67(25):2927-2936.?
[22] Gheorghe L,Ielasi A,Rensing BJWM,et al. Complications following percutaneous mitral valve repair[J].?Front Cardiovasc Med,2019,6:146.
[23] Rahhab Z,Kortlandt FA,Velu JF,et al. Current MitraClip experience,safety and feasibility in the Netherlands[J].?Neth Heart J,2017,25(6):394-400.
[24] Sorini Dini C,Landi D,Meucci F,et al. Unexpected delayed complete atrioventricular block after Cardioband implantation[J].?Catheter Cardiovasc Interv,2018,92(6):1201-1204.
[25] Carrel T,Eberle B,Pasic M. Cardioband to treat functional mitral regurgitation:a word of caution[J]. Eur Heart J,2019,40(5):490.
[26] Eschenbach LK,Prinzing A,Herold U,et al. Surgical explantation of a dehiscent?Cardioband[J].?JACC Cardiovasc Interv,2019,12(9):79-80.
[27] Maisano F,Taramasso M,Guidotti A,et al. The Cardioband:strategies for optimal patient selection and optimised results[J].?EuroIntervention,2016,12(Y):Y61-Y63.

更新日期/Last Update: 2020-12-21